SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001559053-14-000052
Filing Date
2014-11-04
Accepted
2014-11-03 17:40:04
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prta2014q310-q.htm 10-Q 1048721
2 EXHIBIT prta2014q310-qxex311.htm EX-31.1 14356
3 EXHIBIT prta2014q310-qxex312.htm EX-31.2 14422
4 EXHIBIT prta2014q310-qxex321.htm EX-32.1 14636
  Complete submission text file 0001559053-14-000052.txt   6220697

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT prta-20140930.xml EX-101.INS 877021
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20140930.xsd EX-101.SCH 44507
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prta-20140930_cal.xml EX-101.CAL 74048
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prta-20140930_def.xml EX-101.DEF 183920
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20140930_lab.xml EX-101.LAB 527956
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20140930_pre.xml EX-101.PRE 301234
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 650-615-2119
Prothena Corp plc (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35676 | Film No.: 141190527
SIC: 2834 Pharmaceutical Preparations